BRCA2 and neoplasm: FOXO3 methylation levels were significantly higher in BRCA1-mutated tumours compared with BRCA2, BRCAx (non-BRCA1/2) and non-BRCA1-mutated (BRCA2/x) tumours (Figure 12).